Market Value3,138,062,000
Total Holdings76
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
ALEC / Alector, Inc.
SRRK / Scholar Rock Holding Corporation
IGMS / IGM Biosciences, Inc.
AMTI / Applied Molecular Transport Inc.
MORF / Morphic Holding, Inc.
PRTA / Prothena Corporation plc
HLXA / Helix Acquisition Corp - Class A
TSVT / 2seventy bio, Inc.
SBTX / Silverback Therapeutics Inc
ARVN / Arvinas, Inc.
RCUS / Arcus Biosciences, Inc.
ALGS / Aligos Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
GLUE / Monte Rosa Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
VYGR / Voyager Therapeutics, Inc.
AKUS / Akouos Inc
MGTX / MeiraGTx Holdings plc
/ VENTYX BIOSCIENCES INC
ARYD / ARYA Sciences Acquisition Corp IV
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
PARDES BIOSCIENCES ORD / COM ADDED (69945Q105)
KYG9127T1242 / WARRANTS
PRDS / Pardes Biosciences Inc
JYAC / Jiya Acquisition Corp - Class A
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
FMTX / Forma Therapeutics Holdings Inc
ALNY / Alnylam Pharmaceuticals, Inc.
DRNA / Dicerna Pharmaceuticals Inc
ALPN / Alpine Immune Sciences, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
BOLT / Bolt Biotherapeutics, Inc.
NUVB / Nuvation Bio Inc.
IMVT / Immunovant, Inc.
BLSA / BCLS Acquisition Corp - Class A
KNTE / Kinnate Biopharma Inc.
TMPM / Turmeric Acquisition Corp - Class A
FLAC / Frazier Lifesciences Acquisition Corp - Class A
ACIU / AC Immune SA
CRBU / Caribou Biosciences, Inc.
VTVT / vTv Therapeutics Inc.
OMEG / Omega Alpha SPAC - Class A
RPTX / Repare Therapeutics Inc.
CCCC / C4 Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
CYCN / Cyclerion Therapeutics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
GRTS / Gritstone bio, Inc. Call
FVAM / 5:01 Acquisition Corp.
PTGX / Protagonist Therapeutics, Inc.
STTK / Shattuck Labs, Inc.
APLS / Apellis Pharmaceuticals, Inc.
BLUE / bluebird bio, Inc.
ADVM / Adverum Biotechnologies, Inc.
SLDB / Solid Biosciences Inc.
DYN / Dyne Therapeutics, Inc.
GRPH / Graphite Bio, Inc.
ODT / Odonate Therapeutics Inc
MRTX / Mirati Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation Call
ERAS / Erasca, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
SAGE / Sage Therapeutics, Inc.
CRVS / Corvus Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CMAXW / CareMax Inc - Warrants (08/06/2026)
ACAD / ACADIA Pharmaceuticals Inc.
GRTS / Gritstone bio, Inc.
KRON / Kronos Bio, Inc.
NGM / NGM Biopharmaceuticals, Inc. Call
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
TNGX / Tango Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.
PCVX / Vaxcyte, Inc.
KURA / Kura Oncology, Inc.
ANAB / AnaptysBio, Inc.
RLAY / Relay Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
XNCR / Xencor, Inc.
AVIR / Atea Pharmaceuticals, Inc.
DSGN / Design Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
ITOS / iTeos Therapeutics, Inc.